Citations

Clear

14 citation(s) found for "Neumann, Johannes T".

Analytical Performance Evaluation of the Cardiac Troponin T High Sensitivity Gen 6 Assay
Knoll, Marko, Daniels, Lori B. , Mueller, Christian, Mills, Nicholas L, Giannitsis, Evangelos, Rösser, Alisa F A, Kurtoic, Dunja, Wahl, Annika , BODY, R. A. F., Christenson, R H, Cobbaert, Christa, deFilippi, Christopher R, Inoue, Kenji, Jaffe, A. S., McCarthy, C. F., McCord, James, Neumann, Johannes T, Omland, Torbjørn, Papendick, Cynthia , Sandoval, Yader, Than, Martin P, Twerenbold, Raphael, Peacock, W Frank, Meex, Steven J. R., Giannitsis, Evangelos , Body, Richard , Neumann, Franz–Josef , Müller, Christian , Mills, Nicholas L. , Mueller, Christian , Mills, Nicholas L , Giannitsis, Evangelos , Body, Rick , Eggers, Kai M. , Jaffe, Allan S. , Neumann, Johannes T , Sandoval, Yader , Tan, Jack Wei Chieh , Than, Martin , Twerenbold, Raphael , Daniels, Lori B , Cobbaert, Christa M. , deFilippi, Christopher R. , McCarthy, Cian P, McCord, James , Omland, Torbjørn , Sandoval, Yader , Tan, Jack Wei Chieh , Than, Martin , Twerenbold, Raphael , Meex, Steven J.R.

Mayo Clinic

The Journal of Applied Laboratory Medicine | March 26, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/jalm/jfag031 | PMID 41885135 Get It

Abstract Background High-sensitivity cardiac troponin (hs-cTn) assays are recommended for the diagnosis of acute myocardial infarction. Here, we characterize the analytical performance of a next-generation hs-cTn assay, Elecsys® Troponin T hs Gen 6 (Roche Diagnostics International). Methods Surplus lithium-heparin plasma or serum samples from patients or healthy volunteers were run on Cobas® e 801, e 402, and Pro analyzers. Limits of blank (LoB), limits of detection (LoD), and limits of quantitation (LoQ) were determined according to CLSI EP17-A2, with target values of 1.0 and 1.5 ng/L for LoB/LoD and 3.0 ng/L (10% CV) and 1.5 ng/L (20% CV) for LoQ, respectively. Precision was measured, per CLSI EP17-A2, using 3 QC samples (approximately 4, 30, and 220 ng/L), 12 native samples, and 3 reagent lots. Linearity, per CLSI EP06-Ed2, was determined by diluting samples with cardiac troponin T (cTnT) concentration above the measuring range with a low/blank sample. Interference (per Glick) with endogenous and assay components at 5 cTnT concentrations was assessed. Results Measured values for LoB, LoD, and LoQ at 10% and 20% CV were 0.1 to 0.7 ng/L, 0.3 to 1.4 ng/L, 1.0 to 2.9 ng/L, and 0.4 to 1.2 ng/L, respectively. Repeatability CVs were 1.0 to 5.8% for mean cTnT concentrations of 2.6 to 9230 ng/L in lithium-heparin plasma. High precision was shown across lots, and linearity was observed across the measuring range (1.5 to 9500 ng/L, all Pearson's r = 1.00). No interferences were observed, specified up to ≤1000 mg/dL hemoglobin, ≤50 mg/dL [≤855 µmol/L] icterus/bilirubin, and ≤1200 ng/mL biotin. Conclusions The analytical performance characterization of the assay demonstrated high sensitivity, high precision at the low end and across the measuring range, and resistance to interference.
Endoscopist and Patients' Values and Preferences on Artificial Intelligence in Endoscopy: An Intercontinental Opinion Survey by the World Endoscopy Organization
Ahmad, O. F., Groof, A. de, Ali, Aman, Bassett, P., Engels, Megan , Hoogenboom, Sanne A. , Coelho‐Prabhu, N., Yu, H., Parasa, Sravanthi , Vivar, R. Mansilla, Mushtaq, Junaid , Neumann, Helmut, Thakkar, Shyam , Byrne, M. F., Hooft, J. E. van, Yano, Tomonori , Mori, Y., Yu, H , Yano, T , Groof, Albert Jeroen de, Bassett, P, Mwachiro, Michael , Mansilla‐Vivar, Rodrigo , Hooft, Jeanin E. van , Mori, Yuichi

Mayo Clinic

Digestive Endoscopy | February 20, 2026 | Volume: 38 | Issue: 2 | Pages: No page available

10.1111/den.70123 | PMID 41716045 Get It

ABSTRACT Background and Aims Artificial intelligence (AI) is increasingly integrated into gastrointestinal (GI) endoscopy, yet limited data exist on how patients and endoscopists perceive its use. This study aimed to evaluate users' values and preferences regarding AI in endoscopy to support effective implementation and inform guideline development. Methods As part of the World Endoscopy Organization (WEO) AI committee initiatives, two structured international surveys were conducted—one for patients and one for practicing endoscopists. Thirteen AI‐related statements were presented to patients via an established online platform, while 23 statements were shared with endoscopists through professional networks. Responses were captured using 5‐point Likert scales and analyzed with non‐parametric tests, including subgroup comparisons by age, gender, and endoscopic experience. Results A total of 1237 patients and 476 endoscopists participated. Most patients supported AI in image analysis (75.5%) but emphasized the need for endoscopist oversight (92.3%). Among endoscopists, 90.3% believed AI improves endoscopy quality, and 85.3% believed it benefits outcomes. Concerns were raised about liability (47%), operator dependency (34.8%), and procedure time (49%). Most respondents felt primary responsibility for AI‐related errors should rest with the endoscopist. Younger and male patients reported greater trust in AI. Conclusions Patients and endoscopists are generally supportive of AI in GI endoscopy, especially as an adjunct to human expertise. However, key concerns—including accountability, trust, and clinical integration—must be addressed to ensure responsible and effective adoption.
Establishing Reference Values in Healthy Participants for the Cardiac Troponin T High-Sensitivity Gen 6 Assay: REF-TSIX Global Reference Study
Daniels, Lori B. , Mueller, Christian, Giannitsis, Evangelos, Meex, Steven J. R., Buehlmann, David, Dilba, Peter, Bendig, Garnet, Cole, Mette, Body, Richard, Christenson, Robert H, deFilippi, Christopher R, Inoue, Kenji, Jaffe, A S, McCarthy, Cian P. , McCord, J., Neumann, Johannes T, Omland, T., Papendick, Cynthia , Sandoval, Yader, Twerenbold, Raphael, Peacock, W Frank, Mills, Nicholas L, investigators, the TSIX, Jacobs, Michael B., Lucksinger, Gregg, Powell, Richard, Johnson, Daniel, Coleman, Hugh, Fein, M, Surber, Joseph, Vu, Jack B., Hassman, Michael, Hernandez, John, Kirstein, Judith, Tomaszewski, Christian, Runyon, Michael S. , Gong, Jonathan , Wein, D., Andrabi, Sara , Kopin, David , Larrain, Germain, Tahirkheli, Naheem, Clemency, Brian, Abdullah, Shuaib, Hira, Ravi S. , Klausner, H A, Mahler, Simon A. , Crystal, Chad, Headden, Gary, Chaille, Peter, Cannon, Chad Aaron, Limkakeng, Alexander, Tolia, Vaishal , Knapp, Barry J., Massoomi, Mohammad, Sandoval, Yader, Ko, Emily, Luzzi, Verónica, Christenson, Robert, Carson, Jennifer Powers , Cacioppo, F , Kolev, E., Petrov, Andrey, Hazarbasanov, Dobri , Simova, lana, Magimaiseelan, Luci Suganthi, Kosch, Christine, Klein, G, Mehltretter, Kai, Sauter, Joachim, Baumann, Sybille, Moeckel, Martin, Twerenbold, Raphael, Muller-Hennessen, Matthias, Biener, Moritz , Findeisen, P., Omland, Torbjøm, Wilczek-Kosowska, Urszula, Zimmer-Satora, Ewa, Krecipro-Nizińska, Ewa, Miró, O, Díaz, Víctor Jiménez , Mueller, C, Christ, Michael, Lynch, Stephen, BODY, R. A. F., Matsuki, Shunji, Eto, Takashi, Tanaka, Takanori, Hanada, Ryuzo, Nakagami, Takuo, Nakama, T, Kadota, K., Jing, Shan, Yu, Shuwen, Zhang, Hongxuan, Zhang, Jun, Huo, Yong, Zhang, Yan, Yan, Li, Jiang, Longyuan, Chen, Weiqiang, Huang, Jianying, Zhao, Yan, Guan, Ling, Yang, Yanhua, Zhang, Qin, Qiu, Zhaohui, Body, Richard , Neumann, Franz–Josef , Müller, Christian , Mueller, Christian , Body, Rick , Eggers, Kai M. , Jaffe, Allan S. , Neumann, Johannes T , Sandoval, Yader , Tan, Jack Wei Chieh , Than, Martin , Twerenbold, Raphael , Mills, Nicholas L , Daniels, Lori B , Giannitsis, Evangelos , Meex, Steven J.R. , Christenson, Robert H. , Cobbaert, Christa M. , deFilippi, Christopher R. , McCord, James , Omland, Torbjørn , Sandoval, Yader , Tan, Jack Wei Chieh , Than, Martin , Twerenbold, Raphael , Surber, Joseph, Tomaszewski, Christian, Clemency, Brian, Headden, Gary , Cannon, Chad, Knapp, Barry , Tran, Nam K , Niederdöckl, Jan Daniel , Kolev, Emil, Popov, Todor, Sauter, Joachim, Baumann, Sybille , Möeckel, Martin , Müller‐Hennessen, Matthias, Findeisen, Peter, Scharnhorst, Volkher , Omland, T, Krecipro-Nizińska, Ewa, Christ, Michael , Nakagami, Takuo, Huo, Yong

Mayo Clinic

Clinical Chemistry | January 18, 2026 | Volume: 72 | Issue: 4 | Pages: 488-502

10.1093/clinchem/hvag011 | PMID 41564003 Get It

Abstract Background Measurement of cardiac troponin (cTn) using high-sensitivity assays is recommended for the diagnosis of myocardial infarction. We determined sex-specific and uniform 99th percentile upper reference limits (URLs) using the new Elecsys® Troponin T high-sensitivity Gen 6 assay in a global, healthy reference range cohort. Methods Lithium-heparin plasma and serum samples were prospectively collected from apparently healthy individuals aged ≥20 years across 34 global sites in the United States, Europe, China, and Japan. cTnT was measured using the Troponin T high-sensitivity Gen 6 assay on the Cobas® e 801 analyzer. Exclusion criteria were defined according to the 2022 IFCC guidance. Uniform and sex-specific 99th percentile URLs and nonparametric 95% CIs were determined in plasma and serum separately and combined. Results The final study population comprised 4147 participants (52.5% female) with a median (25th–75th percentiles) age of 48.0 (33.0–59.0) years; 45.8%, 47.9%, 5.2%, and 1.1% were White, Asian, Black, and other/unknown, respectively. For sample matrices combined (n = 8294), 81.0% and 99.2% of cTnT values were above the limit of detection in females and males, respectively. Sex-specific 99th percentile URLs (95% CI) were 18 (16–23) ng/L for females and 32 (28–35) ng/L for males; the uniform 99th percentile URL was 27 (24–31) ng/L. URLs were comparable in plasma and serum samples. Conclusions This study determined sex-specific and uniform 99th percentile URLs for the Troponin T high-sensitivity Gen 6 assay that were comparable irrespective of the matrix used in a large, global, healthy reference population.
Endoscopist sentiments on artificial intelligence in endoscopy: A Large-scale intercontinental opinion survey
Groof, Jeroen de , Ahmad, Omer F. , Engels, Megan , Hoogenboom, Sanne A. , Yu, Honggang , Parasa, Sravanthi , Mushtaq, Junaid, Neumann, Helmut , Thakkar, Shyam , Yuichi, M., Coelho–Prabhu, Nayantara , Mwachiro, Michael , Mansilla, R., Byrne, Michael F. , Hooft, Jeanin E. van , Yano, Tomonori , Yuichi, M.

Mayo Clinic

Endoscopy | April 23, 2024 | Volume: 56 | Issue: S 02 | Pages: S353-S353

10.1055/s-0044-1783562 Get It

Patients’ sentiments on artificial intelligence in endoscopy: A large-scale intercontinental opinion survey
Groof, Jeroen de , Ahmad, Omer F. , Engels, Megan , Hoogenboom, Sanne A. , Yu, Honggang , Parasa, Sravanthi , Mushtaq, Junaid, Neumann, Helmut , Thakkar, Shyam , Tomonori, Y., Yuichi, M., Coelho–Prabhu, Nayantara , Mwachiro, Michael , Mansilla, R., Byrne, Michael F. , Hooft, Jeanin E. van , Yuichi, M.

Mayo Clinic

Endoscopy | April 23, 2024 | Volume: 56 | Issue: S 02 | Pages: S324-S325

10.1055/s-0044-1783486 Get It

Performance measures for colonoscopy in inflammatory bowel disease patients: European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative
Dekker, Evelien , Nass, Karlijn J., Iacucci, Marietta , Murino, Alberto , Carretero, Cristina , Cortas, George, Despott, Edward J. , Keuchel, Martin , Monged, Ashraf , Neumann, Helmut , Omar, M. , Rutter, Matthew D. , Bisschops, Raf , Karstensen, John Gásdal , Neumann, Helmut , Pellisé, Maria , Rutter, Matthew D , Bisschops, Raf , Dekker, Evelien , Iacucci, Marietta , Sabino, João , Bugajski, Marek , East, James E. , Kaminski, Michal Filip , Löwenberg, Mark , Nardone, Olga Maria , Omar, Mahmoud M., Peyrin‐Biroulet, Laurent

Mayo Clinic

Endoscopy | August 1, 2022 | Volume: 54 | Issue: 09 | Pages: 904-915

10.1055/a-1874-0946 | PMID 35913069 Get It

AbstractThe European Society of Gastrointestinal Endoscopy (ESGE) presents a short list of performance measures for colonoscopy in inflammatory bowel disease (IBD) patients. Current performance measures for colonoscopy mainly focus on detecting (pre)malignant lesions. However, these performance measures are not relevant for all colonoscopy indications in IBD patients. Therefore, our aim was to provide endoscopy services across Europe and other interested countries with a tool for quality monitoring and improvement in IBD colonoscopy. Eight key performance measures and one minor performance measure were recommended for measurement and evaluation in daily endoscopy practice.
Definition of competence standards for optical diagnosis of diminutive colorectal polyps: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement
Houwen, Britt B. S. L. , Hassan, Cesare , Greuter, Marjolein J.E. , Hazewinkel, Yark, Vleugels, Jasper L.A., Antonelli, Giulio , Bustamante, Marco , Coron, Emmanuel , Cortas, George, Dinis‐Ribeiro, Mário , Dobru, Daniela , Iacucci, Marietta , Jover, Rodrigo , Kuvaev, Roman , Neumann, Helmut , Rutter, Matthew D. , Saunders, Brian P. , Tate, David J. , Bisschops, Raf , Dekker, Evelien , Bustamante-Balén, Marco , Neumann, Helmut , Pellisé, Maria , Puig, Ignasi , Rutter, Matthew D , Mori, Yuichi , Bisschops, Raf , Dekker, Evelien , Hassan, Cesare , Iacucci, Marietta , Coupé, Veerle M.H. , East, James E. , Mori, Yuichi , Longcroft‐Wheaton, Gaius

Mayo Clinic

Endoscopy | December 6, 2021 | Volume: 54 | Issue: 01 | Pages: 88-99

10.1055/a-1689-5130 | PMID 34872120 Get It

Abstract Background The European Society of Gastrointestinal Endoscopy (ESGE) has developed a core curriculum for high quality optical diagnosis training for practice across Europe. The development of easy-to-measure competence standards for optical diagnosis can optimize clinical decision-making in endoscopy. This manuscript represents an official Position Statement of the ESGE aiming to define simple, safe, and easy-to-measure competence standards for endoscopists and artificial intelligence systems performing optical diagnosis of diminutive colorectal polyps (1 – 5 mm). Methods A panel of European experts in optical diagnosis participated in a modified Delphi process to reach consensus on Simple Optical Diagnosis Accuracy (SODA) competence standards for implementation of the optical diagnosis strategy for diminutive colorectal polyps. In order to assess the clinical benefits and harms of implementing optical diagnosis with different competence standards, a systematic literature search was performed. This was complemented with the results from a recently performed simulation study that provides guidance for setting alternative competence standards for optical diagnosis. Proposed competence standards were based on literature search and simulation study results. Competence standards were accepted if at least 80 % agreement was reached after a maximum of three voting rounds. Recommendation 1 In order to implement the leave-in-situ strategy for diminutive colorectal lesions (1–5 mm), it is clinically acceptable if, during real-time colonoscopy, at least 90 % sensitivity and 80 % specificity is achieved for high confidence endoscopic characterization of colorectal neoplasia of 1–5 mm in the rectosigmoid. Histopathology is used as the gold standard. Level of agreement 95 %. Recommendation 2 In order to implement the resect-and-discard strategy for diminutive colorectal lesions (1–5 mm), it is clinically acceptable if, during real-time colonoscopy, at least 80 % sensitivity and 80 % specificity is achieved for high confidence endoscopic characterization of colorectal neoplasia of 1–5 mm. Histopathology is used as the gold standard. Level of agreement 100 %. Conclusion The developed SODA competence standards define diagnostic performance thresholds in relation to clinical consequences, for training and for use when auditing the optical diagnosis of diminutive colorectal polyps.
Editorial: understanding IBS pathophysiology through “converging channels” of research—authors’ reply
Grover, Madhusudan , Berumen, Antonio , Peters, Stéphanie , Wei, Ting , Breen‐Lyles, Margaret K., Harmsen, William S. , Busciglio, Irene, Burton, Duane D. , Roque, Maria Vazquez , DeVault, Kenneth R. , Camilleri, Michael , Wallace, Michael B. , Dasari, Surendra , Neumann, Helmut , Houghton, Lesley A. , Breen-Lyles, Margaret, Burton, Duane, Vazquez Roque, Maria, Houghton, L A , Wallace, Michael B , Wei, Ting , Peters, Stephanie

Mayo Clinic

Alimentary Pharmacology & Therapeutics | October 16, 2021 | Volume: 54 | Issue: 9 | Pages: 1215-1216

10.1111/apt.16613 | PMID 34637534 Get It

LINKED CONTENTThis article is linked to Grover et al and Elwing & Sayuk papers. To view these articles, visit https://doi.org/10.1111/apt.16591 and https://doi.org/10.1111/apt.16603
Intestinal chemosensitivity in irritable bowel syndrome associates with small intestinal TRPV channel expression
Grover, Madhusudan , Berumen, Antonio , Peters, Stéphanie , Wei, Ting , Breen‐Lyles, Margaret K., Harmsen, William S. , Busciglio, Irene, Burton, Duane D. , Roque, Maria Vazquez , DeVault, Kenneth R. , Camilleri, Michael , Wallace, Michael B. , Dasari, Surendra , Neumann, Helmut , Houghton, Lesley A. , Breen-Lyles, Margaret, Burton, Duane, Vazquez Roque, Maria, Houghton, L A , Wallace, Michael B , Wei, Ting , Peters, Stephanie

Mayo Clinic

Alimentary Pharmacology & Therapeutics | September 2, 2021 | Volume: 54 | Issue: 9 | Pages: 1179-1192

10.1111/apt.16591 | PMID 34472640 Get It

SummaryBackgroundIrritable bowel syndrome (IBS) patients often experience meal‐associated symptoms. However, the underlying mechanisms are unclear.AimTo determine small intestinal mechanisms of lipid‐induced symptoms and rectal hypersensitivity in IBSMethodsWe recruited 26 IBS patients (12 IBS‐C, 14 IBS‐D) and 15 healthy volunteers (HV). In vivo permeability was assessed using saccharide excretion assay. Rectal sensitivity was assessed using a barostat before and after small bowel lipid infusion; symptoms were assessed throughout. Next, an extended upper endoscopy with probe‐based confocal laser endomicroscopy (pCLE) was performed with changes induced by lipids. Duodenal and jejunal mucosal biopsies were obtained for transcriptomics.ResultsFollowing lipid infusion, a higher proportion of HV than IBS patients reported no pain, no nausea, no fullness and no urgency (P < 0.05 for all). In a model adjusted for sex and anxiety, IBS‐C and IBS‐D patients had lower thresholds for first rectal sensation (P = 0.0007) and pain (P = 0.004) than HV. In vivo small intestinal permeability and mean pCLE scores were similar between IBS patients and HV. Post‐lipid, pCLE scores were higher than pre‐lipid but were not different between groups. Baseline duodenal transient receptor potential vanilloid (TRPV) 1 and 3 expression was increased in IBS‐D, and TRPV3 in IBS‐C. Duodenal TRPV1 expression correlated with abdominal pain (r = 0.51, FDR = 0.01), and inversely with first rectal sensation (r = −0.48, FDR = 0.01) and pain (r = −0.41, FDR = 0.02) thresholds.ConclusionLipid infusion elicits a greater symptom response in IBS patients than HV, which is associated with small intestinal expression of TRPV channels. TRPV‐mediated small intestinal chemosensitivity may mediate post‐meal symptoms in IBS.